Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Linnea Olson has been surviving advanced lung cancer for more than fifteen years. She is a mother, painter, writer and activist. A veteran of four first in human trials, she is particularly passionate about addressing issues particular to clinical trial participation. Linnea advises both pharma and biotech companies, is a frequent presenter for HMS Executive Education Program and sits on the board of the Israel Cancer Research Fund.